Tear fluid plasmin activity after excimer laser photorefractive keratectomy
- PMID: 8206721
Tear fluid plasmin activity after excimer laser photorefractive keratectomy
Abstract
Purpose: Elevated tear fluid plasmin activity may correlate with delayed healing of corneal wounds. The present study was performed to establish the tear fluid plasmin activity after photorefractive keratoablation (PRK).
Methods: Tear fluid aspirated with microcapillaries was subjected to a fluorometric plasmin assay using the 7-amido-4-trifluoromethylcoumarin derivate of the tripeptide H-D-Val-Leu-Lys as substrate.
Results: Tear fluid flow, plasmin activity, and flow-corrected plasmin excretion rate in tears (plasmin flux) were determined preoperatively and 1, 2, and 7 days after PRK. The preoperative tear fluid flow was 6.55 microliters/min (median; range, 1.8 to 21.8 microliters/min), plasmin activity was 1.29 IU/l (median; range, 0.6 to 6.9 IU/l), and the excretion of plasmin in tears was 11.7 microIU/min (median; range, 1.6 to 41.5 microIU). A statistically significant decrease in tear fluid plasmin activity was found during the follow-up period on the first (0.6 IU/l; range, 0.6 to 1.7 IU/l, P < 0.01) and second (0.65 IU/l; range, 0.6 to 1.49 IU/l, P < 0.01) postoperative days. On the other hand, significant elevation of both tear fluid flow and plasmin flux values occurred during the first two postoperative days. The median plasmin flux values on days 1, 2, and 7 were 57.35 microIU/min (range, 16 to 540 microIU/min, P < 0.01), 40.0 microIU/min (range, 13.3 to 222.8 microIU/min, P < 0.01), and 10.2 microIU/min (range, 2.2 to 90.7 microIU/min, P > 0.05), respectively.
Conclusion: The marked elevation of tear fluid flow coincided with the persistence of an epithelial defect. However, because of the acceleration of tear fluid flow, proteolytic activity due to plasmin (IU/l) actually decreases. Consequently, the increased excretion of plasmin in tears (plasmin flux) does not lead to highly elevated plasmin activity, which could inhibit wound healing. It seems to be a natural healing response because all corneas were epithelialized normally by or on day 3.
Similar articles
-
Elevation of tear fluid plasmin activity of contact lens wearers studied with a rapid fluorometric assay.Cornea. 1994 May;13(3):210-3. doi: 10.1097/00003226-199405000-00003. Cornea. 1994. PMID: 8033569
-
Plasminogen activator activity in tears after excimer laser photorefractive keratectomy.Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3743-7. Invest Ophthalmol Vis Sci. 2000. PMID: 11053271
-
Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRK.Exp Eye Res. 2001 Jun;72(6):631-41. doi: 10.1006/exer.2001.0999. Exp Eye Res. 2001. PMID: 11384151
-
Proteinases of the cornea and preocular tear film.Vet Ophthalmol. 2007 Jul-Aug;10(4):199-206. doi: 10.1111/j.1463-5224.2007.00546.x. Vet Ophthalmol. 2007. PMID: 17565550 Review.
-
Enzyme histochemistry of corneal wound healing.Histol Histopathol. 1998 Apr;13(2):553-64. doi: 10.14670/HH-13.553. Histol Histopathol. 1998. PMID: 9589908 Review.
Cited by
-
Increased release of tenascin in tear fluid after photorefractive keratectomy.Graefes Arch Clin Exp Ophthalmol. 1995 Aug;233(8):479-83. doi: 10.1007/BF00183428. Graefes Arch Clin Exp Ophthalmol. 1995. PMID: 8537022
-
Ligneous conjunctivitis: biochemical evidence for hypofibrinolysis.Inflammation. 2000 Feb;24(1):45-71. doi: 10.1023/a:1006988025799. Inflammation. 2000. PMID: 10704063
-
Increased release of tumour necrosis factor-alpha in human tear fluid after excimer laser induced corneal wound.Br J Ophthalmol. 1997 Feb;81(2):145-9. doi: 10.1136/bjo.81.2.145. Br J Ophthalmol. 1997. PMID: 9059250 Free PMC article.
-
Effect of the combination of basic fibroblast growth factor and cysteine on corneal epithelial healing after photorefractive keratectomy in patients affected by myopia.Indian J Ophthalmol. 2014 Apr;62(4):424-8. doi: 10.4103/0301-4738.119420. Indian J Ophthalmol. 2014. PMID: 24145571 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical